The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 888.00
Bid: 894.00
Ask: 904.00
Change: 6.00 (0.68%)
Spread: 10.00 (1.119%)
Open: 896.00
High: 900.00
Low: 878.00
Prev. Close: 882.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

28 Jan 2020 07:00

RNS Number : 0771B
Mortgage Advice Bureau(Holdings)PLC
28 January 2020
 

28 January 2020

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative networks, today issues a trading update for the year ended 31 December 2019, ahead of publishing its final results on Tuesday, 24 March 2020(1).

Revenue for the year increased by 16% to £143m, with strong organic revenue growth of 10% (11% on an underlying basis(2)) to £135m for the core MAB business driven by a 14% increase in the average number of core MAB Advisers for the year to 1,293 (2018: 1,130). First Mortgage Direct Limited ("First Mortgage"), which was acquired on 2 July 2019, contributed an additional £8m of revenue.

We increased the total number of Advisers at the year end by 20% to 1,457 (2018:1,213), with organic growth in adviser numbers of 13% or 162 to 1,375, supplemented by the 82 Advisers brought into the Group with First Mortgage. 

Activity in the housing market was impacted by the continuing political and economic uncertainties associated with Brexit, particularly in the earlier part of 2019, and we saw a drop in underlying average annual revenue per Adviser for the core MAB business of 3%. However, we have seen improving productivity through H2 2019, relative to H1 2019, and we expect the UK General Election result along with the many focused initiatives that MAB has in place, including process efficiencies and lead generation, supported by our technology developments, to generate growth in revenue per Adviser in 2020, irrespective of the level of activity in the broader market. 

UK Finance(3) estimates that gross new mortgage lending for 2019 was £266bn, a 1% reduction on 2018. The Intermediary Mortgage Lenders Association's current estimates (published post the general election) are £268bn for gross new mortgage lending in 2020 and £275bn in 2021.

The Group's profit before tax for the year ended 31 December 2019 is in line with the Board's expectations. At 31 December 2019, the Group had a strong balance sheet with a cash position of £21m, including £7m of unrestricted cash balances. At the year end the Group had no borrowings drawn down on its revolving credit facility (which was put in place at the time of the First Mortgage acquisition), demonstrating the strong cash generation of MAB's business model.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2019 will be paid on 29 May 2020 to shareholders on the register at close of business on 1 May 2020.

(2) Underlying basis excludes a one-off adjustment in H1 2018 of £1.7m for procuration fees awaiting processing

(3) UK Finance estimates for gross new mortgage lending for 2020 and 2021 were published before the general election in December 2019

Peter Brodnicki, CEO of MAB, said:

"MAB has delivered another strong performance despite the prolonged political and economic uncertainties throughout 2019. We continue to deliver on our strategy to grow our market share in all conditions by investing to ensure sustainable growth whilst maintaining a strong financial position. 

"We are capitalising upon our protection and lead generation initiatives to further improve performance and continue to pilot our new technology platform, with rollout to a number of our ARs in the first half of 2020. These initiatives are important recruitment drivers for ARs, Advisers and lead sources."

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Hugo Rubinstein (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEWEFWESSEFF
Date   Source Headline
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding
16th Jun 202311:49 amRNSDirector/PDMR Shareholding
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.